Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology _ Pancreas, Pancreatic
Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA)

Organization & Developments: Momenta

Parents

2011: Momenta, Baxter Team Up on Biosimilars (2011)
2014: Momenta gets orphan designation for potential pancreatic cancer drug
2020: J&J inks industry's latest bolt-on buyout with $6.5B deal to acquire Momenta, beefing up its autoimmune pipeline
FDA approved Momenta’s generic version of Lovenox, a blood-thinning drug from Sanofi (SNY) used in hospitals to prevent thrombosis.
Glycobiology to drug discovery and development by enabling the high throughput, detailed characterization, and engineering of su
leverages its proprietary technology to unlock the structural secrets of complex sugars and other complex mixtures
M118 is a next-generation anticoagulant designed specifically for use in treating patients diagnosed with Acute Coronary Syndrom
Momenta partners with Novartis’ (NVS) generic unit, Sandoz.
Sanofi fought the approval.
The FDA’s action was good news for generics in general, since it opened the door a crack to future approvals of generic biologic drugs.